Previous Article | Next Article 
Infection and Immunity, November 2001, p. 6893-6901, Vol. 69, No. 11
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.11.6893-6901.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Identification of a Group 1-Like Capsular
Polysaccharide Operon for Vibrio vulnificus
Anita C.
Wright,1,2,3,*
Jan L.
Powell,3
James B.
Kaper,1 and
J. Glenn
Morris Jr.3
Department of Microbiology and
Immunology1 and Department of
Medicine,3 University of Maryland School of
Medicine, Baltimore, Maryland 21201, and Food Science and
Human Nutrition Department, University of Florida, Gainesville,
Florida 326112
Received 23 March 2001/Returned for modification 22 May
2001/Accepted 14 August 2001
 |
ABSTRACT |
Virulence of Vibrio vulnificus correlates with
changes in colony morphology that are indicative of a reversible phase
variation for expression of capsular polysaccharide (CPS). Encapsulated variants are virulent with opaque colonies, whereas phase variants with
reduced CPS expression are attenuated and are translucent. Using
TnphoA mutagenesis, we identified a V.
vulnificus CPS locus, which included an upstream
ops element, a wza gene
(wzaVv), and several open reading frames
with homology to CPS biosynthetic genes. This genetic organization is
characteristic of group 1 CPS operons. The wza
gene product is required for transport of CPS to the cell surface in
Escherichia coli. Polar transposon mutations in
wzaVv eliminated expression of downstream
biosynthetic genes, confirming operon structure. On the other
hand, nonpolar inactivation of wzaVv was
specific for CPS transport, did not alter CPS biosynthesis, and could
be complemented in trans. Southern analysis of CPS phase
variants revealed deletions or rearrangements at this locus. A survey
of environmental isolates indicated a correlation between deletions in
wzaVv and loss of virulent phenotype, suggesting a genetic mechanism for CPS phase variation. Full virulence in mice required surface expression of CPS and supported the essential role of capsule in the pathogenesis of V.
vulnificus.
 |
INTRODUCTION |
Vibrio vulnificus is
indigenous to the estuarine environment and can produce rapidly fatal
human infections associated with consumption of raw oysters.
Pathogenesis of this gram-negative species involves a combination of
host-pathogen interactions that are not completely understood.
Predisposing host factors include iron overload, hepatic disease, and
immune system dysfunction (3, 22, 45). This organism
asymptomatically colonizes both fish (8) and shellfish
(51) at relatively high levels (103
to 106 CFU/g of body weight) during warmer
months, but mouse models, using exogenous iron, suggest that the
infectious dose may be <10 CFU (48). Mortalities exceed
50% for septicemic patients, and V. vulnificus disease remains the leading cause of fatal
infections associated with seafood consumption (37).
Although symptoms of V. vulnificus
septicemia resemble endotoxic shock, the lipopolysaccharide (LPS) of
this organism is relatively inert, and the contribution of LPS to
virulence remains unclear (24, 31). Conversely, expression
of capsular polysaccharide (CPS) is clearly a prerequisite for
virulence and correlates with lethality in mice (41, 54), resistance to phagocytosis (46) and complement-mediated
lysis (40), cytokine induction (31), and
opaque colonies. Phase variation to a phenotype with reduced CPS
expression occurs at a frequency of about 10
4
and correlates with translucent colonies, increased serum
sensitivity, and reduced virulence. CPS is a protective antigen in
mice (9, 18), and its relationship to
V. vulnificus disease was confirmed by the
loss of virulence in acapsular transposon mutants (49, 52). CPS-independent virulence factors indicate that
pathogenesis is multifactorial (23, 28, 42), but opaque
and translucent phenotypes remain the most reliable predictors of virulence.
Polysaccharide capsules contribute to the virulence of many bacterial
pathogens, and specific capsular types are often associated with
systemic disease. CPS types in Escherichia coli have been grouped on the basis of their biochemistry, physiology, and genetics (30, 38), and these groups have been reviewed recently and restructured (47). Group 1 and colanic acid
polysaccharides are primarily comprised of uronic acid sugars, are
regulated by the rcs locus, and are generally induced at low
temperatures (<20°C). Related structures are described for
Klebsiella and Erwinia species. Group 1 operons are expressed as large transcripts and include unique,
highly conserved transport genes such as wza. Group 2 polysaccharides are homopolymers of sialic acid, mapping to a different
genetic locus from that of group 1, and homologues are described for
Haemophilus and Neisseria species. Groups 2 and 3 share genomic loci and transport systems but differ in operon organization and relationship to CPS or 2-keto-3-deoxyoctulosonic acid
(KDO) synthesis. Group 4 strains exhibit the "O-antigen capsule" or
Klps associated with a lipid A core and
map to the rfb locus.
The genetics of CPS biosynthesis and transport for V. vulnificus have not been defined, and the relationship among
capsular types for this species and other CPS groups is unclear.
V. vulnificus strains exhibit great
diversity in CPS carbohydrate composition, but many contain uronic acid
sugars similar to group 1 CPS (7, 33). An epimerase gene
was recently reported to be required for CPS expression, but the
relationship of this gene to a particular CPS locus was not
demonstrated (55). We previously reported phenotypic
analysis of CPS expression for several mutants that were either unable
to synthesize CPS or that produced CPS but did not translocate capsule
to the cell surface (50, 53). In the present study, we
detail the genetics of these mutations to identify a CPS locus for
V. vulnificus. Genes interrupted by transposon insertions were cloned and examined for sequence homology to
other CPS transport and biosynthetic genes. A CPS transport gene,
wzaVv, was identified and characterized by
nonpolar mutagenesis in V. vulnificus. This
gene previously has been shown to encode an outer membrane protein that
forms a multimeric secretin-like complex for group 1 polysaccharide
transport in E. coli (12). We
examined wzaVv gene function in
V. vulnificus, as well as the relationship
of this gene to virulence and CPS phase variation.
 |
MATERIALS AND METHODS |
Bacterial strains and culture conditions.
V.
vulnificus strains described in Table
1 were cultured in Luria broth (LB;
Difco) or on LB agar at 37 or 30°C and were stored at
70°C in LB
with 50% glycerol. When appropriate, antibiotics were added at the
following concentrations: kanamycin (200 µg/ml), ampicillin (200 µg/ml), tetracycline (10 µg/ml), trimethoprim (50 µg/ml), and
polymyxin (50 u/ml). E. coli was
cultured as described above except that kanamycin (50 µg/ml) and tetracycline (50 µg/ml) were added at different
concentrations.
Cloning, PCR, and DNA sequence analysis.
V.
vulnificus strains and recombinant plasmids are detailed in
Table 1. DNA that flanked transposon insertions in V. vulnificus CVD737 and CVD752 (49) was cloned,
using the kanamycin resistance marker in TnphoA. Plasmid
clones were constructed in pBR325 and transformed into E. coli DH5
(Gibco-BRL) by standard methods (39). These recombinant plasmids were isolated by
polyethylene glycol precipitation and were sequenced by cycle
sequencing using dideoxy chain termination on an automated sequencer
(Applied Biosystems, Inc.). These sequences were used to derive
oligonucleotide primers (UMB Biopolymer Laboratory) for PCR
amplification of DNA in order to recover intact parental DNA. DNA (100 ng) from V. vulnificus M06-24/O was
amplified by PCR using Taq polymerase (Promega) or High
Fidelity polymerase (Boehringer Mannheim) on a thermocycler (MJ
Research) under the following conditions: incubation at 92°C for 5 min followed by 35 cycles of 92°C for 1 min, 57° to 60°C for 2 min, and 72°C for 2 min with a final 10-min extension at 72°C. The
region encompassing the wzaVv gene was
amplified by forward primer 712A (5' ATT CCG TGA CCG ATT GAG CGT
3'), 712C (5' TGC AGC AAG CCA TTA GAG CT 3'), or 712K
(5' CCA GCA ACT TAC GTT CAC TT3') and by reverse primer 752J
(5' GCA GTA GAA GAT ACA CCT AGG 3'). PCR products were gel
purified by Micropure separators (Amicon) and cloned into either T/A
vector pGEM-TEasy (Promega), pBluescript II (Stratagene), or
into pRK404 (10) for complementation studies. Plasmid DNA
or gel-purified PCR products were sequenced as described above. DNA
from multiple isolates of plasmid clones was sequenced in both
directions. Sequence identity searches and alignments were done with
the TFASTA, FASTA, or PILEUP program (GCG Wisconsin Package) or BLAST
(National Center for Biotechnology Information).
Southern analysis and colony blots.
Chromosomal DNA was
extracted with Qiamp Tissue Extraction kits (Qiagen) and digested with
restriction enzymes according to the manufacturer's recommendations
(Promega). DNA was visualized on 0.5 to 1.0% agarose gels with
ethidium bromide and transferred to Zetaprobe GT nylon membranes
(Bio-Rad) using alkaline transfer in 0.4 M NaOH. A NotI
digest of pACW36, which included all of the
wzaVv gene, was gel purified as described
above and labeled with 32P by random priming
(Amersham). Membranes were hybridized with this probe in phosphate
buffer with 7% sodium dodecyl sulfate, washed under stringent
conditions at 65°C in SSC (1× SSC is 0.15 M NaCl plus 0.015 M sodium
citrate) with decreasing amounts of sodium dodecyl sulfate, and
visualized by autoradiography.
Environmental isolates (n = 107) from our culture
collection and that of M. Tamplin were confirmed as V. vulnificus using the species-specific VVAP oligonucleotide
probe and colony blot hybridization (50). VVAP
probe-positive strains were assayed with
wzaVv-specific oligonucleotide probe (712A,
described above) using the same methodology. Chi-square analysis with
one degree of freedom was performed to test the null hypothesis that
the frequency of wzaVv-negative strains was
significantly different in translucent-phase versus opaque-phase
environmental V. vulnificus isolates.
Nonpolar mutagenesis of V. vulnificus
wza.
Clones for marker exchange were derived from pACW15
and constructed by insertion of kanamycin resistance cassettes into a unique SphI site in wzaVv. These
cassettes, previously shown to introduce nonpolar mutations in the
ipa genes of Shigella flexneri (25),
are on SmaI fragments of 850 or 851 bp and include start and
stop codons and a ribosomal binding site but lack transcriptional terminators. Cassettes were inserted into the cloned
wzaVv gene either in frame or with a +1
orientation (pACW29 and pACW30, respectively). EcoRI
fragments containing the interrupted wzaVv
genes from these plasmids were subsequently cloned (pACW31 and pACW32)
into a broad-host-range vector (pRK404) and were transformed into
conjugation-competent E. coli 17S for conjugation
into V. vulnificus. Crossover events were
facilitated by the introduction of another plasmid (pR751) from the
same incompatibility group (IncP) with dual selection for the inserted
kanamycin resistance marker and trimethoprim resistance from pR751.
About 50% of the resulting transconjugates were positive for the
crossover events, as determined by acquisition of translucence.
Insertions were confirmed by PCR and Southern analysis. Phenotypes of
V. vulnificus strains were confirmed by examining their ability to bind CPS-specific monoclonal antibody, as
determined by enzyme-linked immunosorbent assay, immunoelectron microscopy, and flow cytometry, as previously described
(52). The nonpolar mutant was able to synthesize CPS but
did not exhibit surface expression, whereas the transposon mutants
showed no evidence of CPS synthesis.
Complementation of wzaVv mutants.
The intact wzaVv gene, with or without
upstream sequences, was recovered by PCR amplification using conditions
described above and primer pair 712K and 752J or 712C and 752J,
respectively. PCR products were first cloned into pGEMT-Easy (Promega)
in E. coli JM109, and then NsiI
fragments, containing the wzaVv, were further subcloned into the PstI site of pRK404 in
conjugation-competent E. coli 17S to yield pWZA1
(without upstream sequences) or pWZA2 (with upstream sequences). Filter
matings of V. vulnificus M06-24/31T and
either E. coli 17S (pWZA1), E. coli 17S (pWZA2), or E. coli 17S
(pRK404) were performed overnight at 37°C, and transconjugates were
plated to LB agar with tetracycline and polymyxin B. Filter matings
were also performed with V. vulnificus
CVD752 and E. coli 17S (pWZA2). Complementation
was detected by recovery of opaqueness, and CPS expression of
transconjugates was confirmed by the ability to resist the lytic
effects of complement as previously described (49).
Briefly, bacteria were grown to log phase and inoculated into either
fresh or heat-inactivated (56°C for 1 h) human sera at a
concentration of about 107 CFU/ml. Sera and cells
were incubated for 2 h at 37°C, and survival was determined by
standard plate counts using serial dilutions in phosphate-buffered
saline (PBS), and colony morphology was recorded.
Virulence assay.
Fifty percent lethal dose
(LD50) determinations in C57BL/6 female mice
(Charles River) were conducted with or without exogenous iron
supplement as previously described (48). Strains were
inoculated from single colonies into LB and were cultured overnight at
30°C. Fresh LB culture was seeded at a 1:100 dilution from the
corresponding overnight culture and incubated at 30°C for 2 to 3 h. Bacterial cells were collected by centrifugation and washed once
with PBS. Bacterial cell concentrations were estimated by determining
the optical density at 600 nm of washed cells and were confirmed by plate counts. Groups of mice (n = 5) were injected
intraperitoneally with serial log dilutions of each bacterial strain
(0.5 ml/mouse) and PBS (0.2 ml) with or without ferric ammonium citrate
(80 mg); the control group was given PBS alone. Lethality was observed at 24 h, and calculations were determined according to the method of Reed and Muench (34).
 |
RESULTS |
Identification of CPS locus for V.
vulnificus M06-24.
A CPS locus for
V. vulnificus was characterized using
previously described TnphoA mutants, CVD752 and CVD737,
which are acapsular and unable to synthesize CPS (49,
52). The present study details the genetic analysis of
these strains. DNA sequences for regions flanking the insertion sites
in both CVD752 and CVD737 exhibited open reading frames (ORFs)
with DNA identity and amino acid similarity to genes previously
described for CPS biosynthetic and transport function (Table
2). Only ORF 1 (ORF1) from CVD 752 did
not show significant homology to GenBank sequences. ORF2 was homologous to the conserved gene family, wza, which encodes outer
membrane proteins involved in CPS transport. We obtained the complete
sequence for this gene (GenBank accession number AY055488), which we have designated wzaVv according to recently
described nomenclature (35). The remaining partial ORFs
from CVD752 (ORF3) or CVD737 (ORF4 and ORF5 from the 3' end of the
insertion site) also showed homology to known CPS biosynthetic genes.
View this table:
[in this window]
[in a new window]
|
TABLE 2.
Comparison of V. vulnificus DNA
and deduced amino acid sequences to potential homologues for CPS
biosynthesis and transport
|
|
Both transposon insertions localized to the same 23-kb BamHI
fragment, and a partial map of the CPS locus is shown in Fig. 1a. Southern analysis with a
wza probe indicated that both mutants exhibited novel
BamHI restriction sites that were not present in the
parent strain, V. vulnificus M06-24/O (Fig.
1b), or in the phase variant, V. vulnificus
M06-24/T (not shown). These sites were introduced presumably from
the BamHI site in TnphoA. Restriction fragment analysis of these digests, as well as of other restriction enzyme digests (not shown), indicated that the transposon insertion in
V. vulnificus CVD737 was approximately 10 kb
downstream of the insertion in CVD752. Thus, both acapsular transposon
mutants exhibited independent insertions at the same locus, disrupting genes related to either CPS transport or biosynthesis.

View larger version (39K):
[in this window]
[in a new window]
|
FIG. 1.
Analysis of the V.
vulnificus CPS genetic locus. (a) Restriction map for
ClaI (C), HindIII (H),
SphI (S), and EcoRI (E) sites within the
23-kb BamHI (B) fragment of the V.
vulnificus CPS genetic locus. Relative placement and
direction of transcription (horizontal arrows) of ORFs and
wzaVv are shown. Location of 7.7-kb
TnphoA (with a BamHI site at 5 kb) in
V. vulnificus CVD737 and CVD752 is
indicated by triangles. (b) Southern analysis for BamHI
restriction digests of the following V.
vulnificus strains: CVD737, lane 1; CVD752, lane 2; and
M06-24/O, lane 3. DNA was hybridized with the
wzaVv gene probe as described in text.
Approximate size of bands (arrows) was determined by extrapolation from
known size markers of lambda DNA HindIII digests. CVD737
digests probed with wzaVv show a single band
of ca. 16 kb as a product of the new BamHI site
introduced 11 kb downstream from the 5' BamHI site with
an additional 5 kb from TnphoA. The insertion in CVD752
occurred within wzaVv 1.6 kb from the 5'
BamHI site to produce 2 bands of ca. 6.6 and 23.4 kb.
(c) HindIII restriction digests of chromosomal DNA from
the following V. vulnificus strains are
shown: lane 1, M06-24/O; lane 2, M06-24/T; lane 3, M06-24/31T; and lane
4, M06-24/32T. DNA was hybridized with a
wzaVv probe as described in the text, and
the approximate sizes of bands, as determined by comparison to known
markers of lambda DNA HindIII digests, are indicated by
arrows.
|
|
Upstream regulatory sequences for V.
vulnificus wza.
The
wzaVv gene is characteristic of group 1 CPS
operons. Other features common to these operons were
identified upstream of this gene in V. vulnificus. As shown in Fig.
2, ORF1 contains a genetic element,
ops, which is located at the 5' end of all group 1 CPS
operons (47). This element is generally found
within a larger JUMPstart (just upstream of many polysaccharides)
sequence (16). The upstream region also included a
putative promoter containing all eight of the most conserved bases
described for strong E. coli promoters
(15), i.e., the "
10" and "
35" regions and a
potential RNA start site. No ribosomal binding site was identified for
ORF1; however, a possible ribosomal binding site was found for the
wzaVv gene, which preceded the second Met
(amino acid 33) of the deduced amino acid sequence, corresponding to the translational start for other wza homologues.

View larger version (49K):
[in this window]
[in a new window]
|
FIG. 2.
The 5' region of the CPS locus for V.
vulnificus. Single-letter deduced amino acid sequence is
given below nucleotide coding region. Putative promoter region is shown
in boldface, and locations of 10 and 35 sites are indicated above
coding sequence with asterisks over highly conserved nucleotides
(16). Inverted repeats are indicated by horizontal arrows.
The JUMPstart region is underlined, and the ops element
is doubly underlined. Possible ribosomal binding site (RBS) for
wzaVv is boxed and followed by the second
Met (vertical arrow), which aligns translation start site with other
wza homologues.
|
|
Functional analysis of V. vulnificus
wzaVv as CPS transport gene.
To determine the
function of the wzaVv gene product,
nonpolar mutations were introduced at the SphI site (Fig.
1a) of wzaVv and recombined into the
chromosome of V. vulnificus M06-24/O. Insertions of the nonpolar kanamycin cassette into mutant strains M06-24/31T and M06-24/32T were confirmed by increased sizes of a
HindIII fragments in mutants (5.8 kb) compared to the
parental strain (5.0 kb), as indicated by Southern analysis (Fig. 1c)
and by sequencing of PCR products spanning the insertion sites. Mutants were translucent and did not revert to opaque colonies when grown with
or without antibiotic selection. In a previous study, CPS expression
was examined in detail for V. vulnificus
M06-24/O and its derivatives, using a combination of enzyme-linked
immunosorbent assay, flow cytometry, and immunoelectron microscopy
(52). Those results demonstrated that the nonpolar mutant
was able to synthesize CPS but did not translocate the polysaccharide
to the cell surface. This strain differed from the TnphoA
mutants, which do not synthesize the polysaccharide. Closer examination
of electron micrographs confirmed that CPS was detected consistently in
the cytoplasm and occasionally in the periplasm of M06-31T but was not
seen beyond the outer membrane (Fig. 3a).
These results differed from those for the wild-type encapsulated
strain, where label was clearly detected beyond the outer
membrane (Fig. 3b).

View larger version (92K):
[in this window]
[in a new window]
|
FIG. 3.
Immunoelectron micrograph of V.
vulnificus wza mutant. Bacterial thin
sections of wild-type wzaVv mutant
M06-24/31T (A) and M06-24/O (B) were immunolabeled using
V. vulnificus CPS-specific monoclonal
antibody (7/G4-D2) and were visualized by gold-labeled secondary goat
anti-mouse immunoglobulin A conjugate as previously described
(53). Inner membrane (IM) and outer membrane (OM) are
shown for inset, and arrows indicate gold-labeled CPS for
wzaVv mutant M06-24/31T. Bar = 1 µm.
|
|
Introduction of the intact wzaVv gene with
the upstream sequences (pWZA2) into M06-24/31T complemented the
mutation, and all transconjugates had the opaque colonies of the
parental phenotype. However, conjugation of the cloned
wzaVv gene without these upstream sequences
(pWZA1) into M06-24/31T did not complement the mutation, and
transconjugates had translucent colonies. To confirm complementation and CPS expression in M06-31T (pWZA2), resistance to the lytic effects
of complement was examined in this strain. The nonpolar mutant
M06-24/31T was extremely sensitive to complement and exhibited a
>5.0-log-CFU/ml reduction in normal serum in comparison to
heat-inactivated serum. However, complement sensitivity of M06-24/31T
containing the pWZA2 was similar to that of the encapsulated parental
strain, with only 0.1- and 0.2-log reductions in number of CFU per
milliliter, respectively. Conjugation of pWZA2 into transposon mutant
CVD752 or of the vector only into M06-24/31T did not complement in
trans, yielding translucent transconjugates.
Transport of CPS to cell surface increases virulence of
V. vulnificus in mice.
The role of
CPS expression in virulence was examined using a mouse model with or
without exogenous iron. As shown in Table 3, LD50
determinations in mice (n = 5) agreed with previously published data (50). As expected, translucent-phase
variant V. vulnificus M06-24/T was less
virulent than the encapsulated M06-24/O and acapsular TnphoA
mutant V. vulnificus CVD752 was less
virulent than all other strains, with no deaths observed at the highest
concentration of bacteria inoculated (108). The
LD50 was lower for all strains following iron
injections but was dramatically reduced to one bacterium for the
opaque, encapsulated isolate. The LD50 for the
wzaVv mutant without iron was equivalent to
the translucent variant but was intermediate between the
translucent-phase variant and the acapsular transposon mutant for
iron-treated mice.
Sequence comparisons of wza homologues.
The
wza gene family has been reported (47) to
include the E. coli wza for group 1 and colanic
acid CPS (44), amsH of Erwinia amylovora (6), ORF4 of Klebsiella
pneumoniae (1), epsA of Pseudomonas
solanacearum (17), and exoF of
Rhizobium meliloti (36). Deduced amino acid
sequence alignments indicated that homologues from V. vulnificus, E. coli, K. pneumoniae, and E. amylovora are more
closely related to each other than those from P. solanacearum (Fig. 4) or
R. meliloti (not shown). The former group shared
exact conservation of sequence for 163 of 381 (43%) residues. On the
other hand, EpsA shared only 58 of these residues (15%), and alignment
of ExoF of R. meliloti was much closer to that of
E. coli KpsD by BLAST analysis than to that of
Wza homologues (not shown). At amino acid 112, EpsA also exhibited a
12-amino-acid insertion region that was not present in the other
sequences. Other putative outer membrane transport systems include
those from group 2 CPS, such as BexD from Haemophilus
influenzae (19) and CtrA from Neisseria
meningitidis (13, 14), which are more closely related
to each other than to Wza homologues. Interestingly, BexD also
contained an 8-amino-acid insertion found at the same location as the
one in EpsA. Differences between group 1 and group 2 homologues were
reflected in hydropathy analyses of the deduced amino acid sequences
(Fig. 5). BexD, which has been
characterized as a porin with multiple membrane-spanning
regions, was considerably more hydrophobic than the Wza homologues.

View larger version (73K):
[in this window]
[in a new window]
|
FIG. 4.
Comparison of possible Wza homologues. Deduced amino
acid sequences from E. coli
WzaEc, E. amylovora AmsH,
K. pneumoniae ORF4, V.
vulnificus WzaVv, P.
solanacearum EpsA, and H.
influenzae BexD are shown. Identity is indicated by
dashes, and gaps are indicated by periods. Hydrophobic regions are in
boldface, and conserved cysteines at the end of the leader sequences
are boxed.
|
|

View larger version (40K):
[in this window]
[in a new window]
|
FIG. 5.
Hydropathy comparison of deduced amino acid sequences
for CPS outer membrane transport. Hydrophilicity plots of the deduced
amino acid sequences of E. coli
WzaEc, V. vulnificus
WzaVv, and H. influenzae BexD
are shown and were determined using the algorithm of Kyte and Doolittle
(21).
|
|
Conservation and phase variation of
wzaVv sequences among
V. vulnificus strains.
The wza gene of E. coli is highly
conserved among different group 1 K serotypes (47).
Therefore, isolates of V. vulnificus from
clinical and environmental sources were examined for the presence and
diversity of wzaVv. Chromosomal DNA from
the opaque- or translucent-phase variants of V. vulnificus strains M06-24, LC4, 345, and E4125 was amplified
by PCR, using primers derived from sequences flanking the
wzaVv gene. PCR products of identical size
were observed for all strains except the translucent-phase variant
V. vulnificus 345/T (the only environmental
isolate), which did not amplify with these or nested primers. Southern
analysis confirmed deletion of wzaVv in
V. vulnificus 345/T (Fig.
6), and restriction fragment length
polymorphism was observed among all strains. No differences in
restriction fragment lengths were detected between phase
variants of either V. vulnificus M06-24 or
E4125, but a deletion or restriction site polymorphism was seen for the translucent-phase variant of strain LC4.

View larger version (44K):
[in this window]
[in a new window]
|
FIG. 6.
Southern analysis of wzaVv
from opaque- and translucent-phase variants. HindIII
digests of chromosomal DNA extracted from the following strains are
shown: lane 1, M06-24/O; lane 2, M06-24/T; lane 3, E4125/O; lane 4, E4125/T; lane 5, 345/O; lane 6, 345/T; lane 7, LC4/O; and lane 8, LC4/T. Size markers for a lambda DNA HindIII digest are
indicated.
|
|
Additional environmental isolates were examined for the
presence of wzaVv, based on
hybridization with an oligonucleotide probe. The majority (88%) of 97 opaque-phase and presumably encapsulated isolates were positive
for the wzaVv probe, indicating a
high degree of conservation for this gene among V. vulnificus environmental isolates. However, a significantly
greater percentage (50%) of translucent-phase strains
(n = 10) than of opaque-phase strains were negative for
wza (P = 0.007, Fisher's two-tailed exact
test), suggesting a higher deletion rate for translucent-phase than for opaque-phase isolates.
 |
DISCUSSION |
These data represent the first description of a CPS operon
in V. vulnificus. CPS-associated
homologues were identified by transposon mutagenesis and shown to
localize to the same 23-kb chromosomal fragment. Genetic organization
at this locus indicated homology to the group 1 and colanic acid CPS
operons. In E. coli, an 8-bp
ops element always follows the promoter of group 1 and colanic acid CPS operons and is contained within a larger 39-bp consensus region termed JUMPstart. This element exhibits nonrandom distribution throughout the chromosome and functions to suppress transcriptional polarity, greatly enhancing the activity of both homologous and heterologous promoters (26). It is
orientation dependent and requires cotranscription by the promoter.
Within ORF1 of the V. vulnificus sequence,
we identified an ops element contained in a region with 67%
homology to the consensus for JUMPstart. This element in
V. vulnificus was downstream of a putative
promoter, which showed genetic structure similar to the E. coli colanic acid CPS promoter (44). Distances
between promoters and ops elements were almost identical for
V. vulnificus and E. coli (123 and 124 bp, respectively), and both regions
contained multiple inverted repeats that may serve as recognition sites
for DNA-binding proteins. Further, this promoter preceded the CPS
transport gene, wzaVv, which is usually the
first gene in group 1 operons.
The presence of wza is a criterion for group 1 CPS
operon classification (47), and mutational
analysis of wzaVv was consistent with
identification of a V. vulnificus CPS
operon. Mutations in this gene in E. coli
specifically disrupt transport and surface expression of CPS
(11). However, a single-transposon insertion in this
gene in V. vulnificus CVD752 completely
eliminated biosynthetic function as well. The polar effects of
TnphoA insertions have been established for a number of
species, including vibrios (5); therefore, loss of CPS
biosynthesis in CVD752 is due presumably to an inability to transcribe
downstream biosynthetic genes within the CPS operon. On the
other hand, nonpolar mutagenesis of this gene in V. vulnificus M06-31T specifically eliminated transport function without disturbing CPS biosynthesis, and the nonpolar mutation
of wzaVv was complemented in
trans, whereas the introduction of the cloned gene did not
complement the TnphoA mutation in CVD752. Furthermore, a
complementation was achieved with a plasmid construct that included
both the cloned wzaVv and its upstream
promoter region; however, a similar construct, lacking the upstream
DNA, did not complement. Although confirmation will require more
extensive analysis, we predict that transcription of the
V. vulnificus CPS operon begins
upstream of wzaVv.
Deduced amino acid sequences support a specific outer membrane function
for transport of CPS by Wza protein homologues (11), and
studies with E. coli recently confirmed that Wza
proteins form multimeric secretins exposed on the cell surface
(12). TnphoA mutagenesis of the
V. vulnificus wzaVv gene
was consistent with an outer membrane location for the gene product.
TnphoA lacks a signal sequence and will not produce
functional enzyme without a fusion to an exported or secreted gene
product. TnphoA insertion into the
wzaVv gene in V. vulnificus CVD752 resulted in a strain that acquired
alkaline phosphatase activity (49). However, the transposon insertion into cytoplasmic, biosynthetic homologues in
CVD737 did not produce enzymatic activity. These results indicate that
wzaVv provides the signal sequence for the
export of the TnphoA fusion product through the inner
membrane, supporting a periplasmic or outer membrane location for
wza.
Group 2 inner membrane transport genes are well defined, but homologues
have not been found in group 1 CPS operons. Thus, the mechanism
for coordination of inner and outer transport in group 1 is
unknown. The genetic analysis of V. vulnificus CPS mutants reported here, in the context of
previously detailed phenotypic examination (52),
demonstrated specific outer membrane transport function for
wzaVv; the nonpolar mutant was able to
synthesize CPS but lacked cell surface expression. Micrographs of this
mutant differed greatly from E. coli mutants
deficient in either inner membrane or periplasmic transport. Deletion
of group 2 CPS inner membrane transport genes, kpsM and
kpsT, produced strains that accumulated intact CPS in the
cytoplasm, sequestering the polymers in discrete electron-lucent spaces
just below the inner membrane (4, 29). Strains
deficient in the periplasmic protein KpsD accumulated CPS in the
periplasm and exhibited electron-lucent spaces that expanded the
periplasm (53). Micrographs of the nonpolar
wzaVv mutant indicated accumulation of CPS
in the cytoplasm, with relatively little material in the periplasm and
no surface CPS. Zones of adhesion or "Bayer junctions" have been
proposed to span both membranes and form junctions for CPS transport
that bypasses the periplasm altogether (2). The presence
of CPS in the periplasm of the wzaVv mutant
would argue against this hypothesis, but lack of periplasmic CPS
accumulation does suggest coordination of inner and outer membrane transport.
Analyses of deduced amino acid sequences of group 1 wza
homologues indicated that they encode proteins distinct from those described for group 2 CPS transport and are likely to differ in origin
and structure (35). We present evidence that Wza
homologues lack the multiple hydrophobic regions characteristic of the
porin structure of group 2 homologues (i.e., BexD) and agree that the transport mechanisms of groups 1 and 2 are not closely related. However, we also found striking diversity among strains that are generally classified within group 1. Sequence alignments showed that
Wza homologues from V. vulnificus, E. coli, K. pneumoniae, and E. amylovora share much greater overall conservation of
sequence than those of P. solanacearum and
R. meliloti. All Wza homologues include a
lipoprotein signal peptidase II recognition site with a
conserved cysteine (amino acid 22 of the E. coli
Wza), characteristic of outer membrane proteins (6, 32,
43), but the former group has a common threonine at the
membrane-sorting signal site that was not found in the latter species.
In addition, both of the latter strains contain insertions not
found in the other sequences. Therefore, we suggest that the grouping
of homologues from P. solanacearum and
R. meliloti within the wza gene family
requires further examination.
Loss of virulence in acapsular transposon mutants presumably
results from decreased anticomplement and antiphagocytic
protection. The virulence of genetically undefined
translucent-phase variants, expressing patchy and incomplete
capsules, was intermediate between opaque-phase variants and acapsular
mutants (49, 52). Thus, residual CPS expression by
translucent-phase variants may confer some degree of protection and
implies a correlation of virulence with the amount of CPS expressed.
Alternatively, a small number of cells within the translucent-phase
population may revert to the opaque-phase phenotype and function to
lower the LD50, especially in the presence of
exogenous iron. Interestingly, the wzaVv
nonpolar transport mutant, which lacks surface CPS and does not revert to the opaque phase, was also more virulent than the acapsular transposon mutants. Thus, in vivo release of intracellular polymer from
the wzaVv mutant may contribute directly to
the disease process in a manner that is independent of its surface
properties. Recent observations have indicated that, during infections
in mice, V. vulnificus CPS elicits
inflammatory host cytokines, which may contribute to pathogenesis by
inducing toxic shock (31). Therefore, virulence analysis
of V. vulnificus strains was consistent with an inflammatory role for CPS; however, full virulence required complete
encapsulation of the bacteria.
Phase variation of CPS expression is common and has been attributed to
insertional inactivation of CPS genes by insertion elements
(27) or deletion mutations (20). Deletions or
rearrangements of wzaVv were more frequent
among V. vulnificus that were translucent than among those that were opaque, suggesting that
wzaVv is a possible target for phase
variation. However, translucent-phase V. vulnificus strains with intact
wzaVv genes, as well as
wzaVv-negative opaque-phase isolates, were
observed and indicated that other mechanisms for phase variation exist.
These data also raise the question of whether multiple CPS
operons may exist for V. vulnificus strains, as they do for E. coli. The previously
reported V. vulnificus epimerase gene was
required for CPS expression, but operon structure was not
demonstrated (55). This gene showed extensive identity to
a sequence found in the V. cholerae O139 CPS
operon, which is not related to group 1 operons and
appears to be derived from an insertion of CPS genes into a LPS locus.
We are presently evaluating the linkage of the epimerase gene to the
group 1 operon described here, as well as the possibility of
multiple CPS operons.
In summary, this study identified a group 1-like CPS operon for
V. vulnificus. Experimental analysis
provided evidence to support the role of the wza gene family
in outer membrane transport of bacterial polysaccharides. Despite great
variation in CPS composition within this species, this transport gene
was highly conserved among different strains of V. vulnificus, and naturally occurring deletions observed in
wzaVv may represent at least one of the mechanisms responsible for phase variation. Finally, animal studies confirmed the essential contribution of capsule expression as a
virulence determinant for V. vulnificus.
 |
ACKNOWLEDGMENTS |
Funding was provided in part by a Merit Review grant from the
Department of Veterans Affairs and by a grant from the United States
Department of Agriculture (2001-35201-09954).
We thank Anne Sill for the statistical analysis and Lynne Ensor for
electron micrographs.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Food Science and
Human Nutrition Department, University of Florida, P.O. Box 10370, Gainesville, FL 32611-0370. Phone: (352) 392-1991 ext. 311. Fax: (352)
392-9467. E-mail: awright{at}gnv.ifas.ufl.edu.
Editor:
V. J. DiRita
 |
REFERENCES |
| 1.
|
Arakawa, Y.,
R. Wacharotayankun,
T. Nagatsuka,
H. Ito,
N. Kato, and M. Ohta.
1995.
Genomic organization of the Klebsiella pneumoniae cps region responsible for serotype K2 capsular polysaccharide synthesis in the virulent strain Chedid.
J. Bacteriol.
177:1788-1796[Abstract/Free Full Text].
|
| 2.
|
Bayer, M., and M. H. Bayer.
1994.
Biophysical and structural aspects of the bacterial capsule.
ASM News
60:192-198.
|
| 3.
|
Blake, P. A.,
M. H. Merson,
R. E. Weaver,
D. G. Hollis, and P. C. Heublein.
1979.
Disease caused by a marine Vibrio. Clinical characteristics and epidemiology.
N. Engl. J. Med.
300:1-5[Abstract].
|
| 4.
|
Bronner, D.,
V. Seiberth,
C. Pazzani,
S. Roberts,
G. J. Boulnois,
B. Jann, and K. Jann.
1993.
Expression of the capsular K5 polysaccharide of Escherichia coli: biochemical and electron microscopic analyses of mutants with defects in region 1 of the gene cluster.
J. Bacteriol.
175:5984-5992[Abstract/Free Full Text].
|
| 5.
|
Brown, R. C., and R. K. Taylor.
1995.
Organization of tcp, acf, and toxT genes within a ToxT-dependent operon.
Mol. Microbiol.
16:425-439[CrossRef][Medline].
|
| 6.
|
Bugert, P., and K. Geider.
1995.
Molecular analysis of the ams operon required for exopolysaccharide synthesis of Erwinia amylovora.
Mol. Microbiol.
15:917-933[Medline].
|
| 7.
|
Bush, C. A.,
P. Patel,
S. Gunawardena,
J. Powell,
A. Joseph,
J. A. Johnson, and J. G. Morris.
1997.
Classification of Vibrio vulnificus strains by the carbohydrate composition of their capsular polysaccharides.
Anal. Biochem.
250:186-195[CrossRef][Medline].
|
| 8.
|
DePaola, A.,
G. M. Capers, and D. Alexander.
1994.
Densities of Vibrio vulnificus in the intestines of fish from the U.S.
Gulf Coast. Appl. Environ. Microbiol.
60:984-988.
|
| 9.
|
Devi, S. J.,
U. Hayat,
J. L. Powell, and J. G. Morris, Jr.
1996.
Preclinical immunoprophylactic and immunotherapeutic efficacy of antisera to capsular polysaccharide-tetanus toxoid conjugate vaccines of Vibrio vulnificus.
Infect. Immun.
64:2220-2224[Abstract].
|
| 10.
|
Ditta, G.,
T. Schmidhauser,
E. Yakobson,
P. Lu,
X. W. Liang,
D. R. Finlay,
D. Guiney, and D. R. Helinski.
1985.
Plasmids related to the broad host range vector, pRK290, useful for gene cloning and for monitoring gene expression.
Plasmid
13:149-153[CrossRef][Medline].
|
| 11.
|
Drummelsmith, J., and C. Whitfield.
1999.
Gene products required for surface expression of the capsular form of the group 1 K antigen in Escherichia coli (O9a:K30).
Mol. Microbiol.
31:1321-1332[CrossRef][Medline].
|
| 12.
|
Drummelsmith, J., and C. Whitfield.
2000.
Translocation of group 1 capsular polysaccharide to the surface of Escherichia coli requires a multimeric complex in the outer membrane.
EMBO J.
19:57-66[CrossRef][Medline].
|
| 13.
|
Frosch, M.,
U. Edwards,
K. Bousset,
B. Krausse, and C. Weisgerber.
1991.
Evidence for a common molecular origin of the capsule gene loci in gram-negative bacteria expressing group II capsular polysaccharides.
Mol. Microbiol.
5:1251-1263[CrossRef][Medline].
|
| 14.
|
Frosch, M.,
D. Muller,
K. Bousset, and S. Muller.
1992.
Conserved outer membrane protein of Neisseria meningitidis involved in capsule expression.
Infect. Immun.
60:798-803[Abstract/Free Full Text].
|
| 15.
|
Gentz, R., and H. Bujard.
1985.
Promoters recognized by Escherichia coli RNA polymerase selected by function: highly efficient promoters from bacteriophage T5.
J. Bacteriol.
164:70-77[Abstract/Free Full Text].
|
| 16.
|
Hobbs, M., and P. R. Reeves.
1994.
The JUMPstart sequence: a 39 bp element common to several polysaccharide gene clusters.
Mol. Microbiol.
12:855-856[CrossRef][Medline].
|
| 17.
|
Huang, J., and M. Schell.
1995.
Molecular characterization of the eps gene cluster of Pseudomonas solanacearum and its transcriptional regulation at a single promoter.
Mol. Microbiol.
16:677-689.
|
| 18.
|
Kreger, A. S.,
L. D. Gray, and J. Testa.
1984.
Protection of mice against Vibrio vulnificus disease by vaccination with surface antigen preparation and anti-surface antigen antisera.
Infect. Immun.
45:537-543[Abstract/Free Full Text].
|
| 19.
|
Kroll, J. S.,
B. Loynds,
L. M. Brophy, and E. R. Moxon.
1990.
The bex locus in encapsulated Haemophilus influenzae: a chromosomal region involved in capsule polysaccharide export.
Mol. Microbiol.
4:1853-1862[Medline].
|
| 20.
|
Kroll, J. S.,
E. R. Moxon, and B. M. Loynds.
1993.
An ancestral mutation enhancing the fitness and increasing the virulence of Haemophilus influenzae type b.
J. Infect. Dis.
168:172-176[Medline].
|
| 21.
|
Kyte, J., and R. F. Doolittle.
1982.
A simple method for displaying the hydropathic character of a protein.
J. Mol. Biol.
157:105-132[CrossRef][Medline].
|
| 22.
|
Linkous, D. A., and J. D. Oliver.
1999.
Pathogenesis of Vibrio vulnificus.
FEMS Microbiol. Lett.
174:207-214[CrossRef][Medline].
|
| 23.
|
Litwin, C. M.,
T. W. Rayback, and J. Skinner.
1996.
Role of catechol siderophore synthesis in Vibrio vulnificus virulence.
Infect. Immun.
64:2834-2838[Abstract].
|
| 24.
|
McPherson, V. L.,
J. A. Watts,
L. M. Simpson, and J. D. Oliver.
1991.
Physiological effects of the lipopolysaccharide of Vibrio vulnificus on mice and rats.
Microbios
67:141-149[Medline].
|
| 25.
|
Menard, R.,
P. J. Sansonetti, and C. Parsot.
1993.
Nonpolar mutagenesis of the ipa genes defines IpaB, IpaC, and IpaD as effectors of Shigella flexneri entry into epithelial cells.
J. Bacteriol.
175:5899-5906[Abstract/Free Full Text].
|
| 26.
|
Nieto, J. M.,
M. J. A. Bailey,
C. Hughes, and V. Koronakis.
1996.
Suppression of transcription polarity in the Escherichia coli haemolysin operon by a short upstream element shared by polysaccharide and DNA transfer determinants.
Mol. Microbiol.
19:705-713[CrossRef][Medline].
|
| 27.
|
Ou, J. T.,
L. S. Baron,
F. A. Rubin, and D. J. Kopecko.
1988.
Specific insertion and deletion of insertion sequence 1-like DNA element causes the reversible expression of the virulence capsular antigen Vi of Citrobacter freundii in Escherichia coli.
Proc. Natl. Acad. Sci. USA
85:4402-4405[Abstract/Free Full Text].
|
| 28.
|
Paranjpye, R. N.,
J. C. Lara,
J. C. Pepe,
C. M. Pepe, and M. S. Strom.
1998.
The type IV leader peptidase/N-methyltransferase of Vibrio vulnificus controls factors required for adherence to HEp-2 cells and virulence in iron-overloaded mice.
Infect. Immun.
66:5659-5668[Abstract/Free Full Text].
|
| 29.
|
Pavelka, M. S., Jr.,
S. F. Hayes, and R. P. Silver.
1994.
Characterization of KpsT, the ATP-binding component of the ABC-transporter involved with the export of capsular polysialic acid in Escherichia coli K1.
J. Biol. Chem.
269:20149-20158[Abstract/Free Full Text].
|
| 30.
|
Pearce, R., and I. S. Roberts.
1995.
Cloning and analysis of gene clusters for production of the Escherichia coli K10 and K54 antigens: identification of a new group of serA-linked capsule gene clusters.
J. Bacteriol.
177:3992-3997[Abstract/Free Full Text].
|
| 31.
|
Powell, J. L.,
A. C. Wright,
S. W. Wasserman,
D. M. Hone, and J. G. Morris, Jr.
1997.
Release of tumor necrosis factor alpha in response to Vibrio vulnificus capsular polysaccharide using in vivo and in vitro models.
Infect. Immun.
65:3713-3718[Abstract].
|
| 32.
|
Pugsley, A. P.
1993.
The complete general secretory pathway in gram-negative bacteria.
Microbiol. Rev.
57:50-108[Abstract/Free Full Text].
|
| 33.
|
Reddy, G. P.,
U. Hayat,
C. Abeygunawardana,
C. Fox,
A. C. Wright,
D. R. Manevel, Jr.,
C. A. Bush, and J. G. Morris, Jr.
1992.
Purification and determination of the structure of capsular polysaccharide of Vibrio vulnificus M06-24.
J. Bacteriol.
174:2620-2630[Abstract/Free Full Text].
|
| 34.
|
Reed, L. J., and H. Meunch.
1938.
A simple method of estimating the fifty percent endpoints.
Am. J. Hyg.
27:493-497.
|
| 35.
|
Reeves, P. R.,
M. Hobbs,
M. A. Valvano,
M. Skurnik,
C. Whitfield,
D. Coplin,
N. Kido,
J. Klena,
D. Maskell,
C. R. Raetz, and P. D. Rick.
1996.
Bacterial polysaccharide synthesis and gene nomenclature.
Trends Microbiol.
4:495-503[CrossRef][Medline].
|
| 36.
|
Reuber, T. L., and G. C. Walker.
1993.
Biosynthesis of succinoglycan, a symbiotically important exopolysaccharide of Rhizobium meliloti.
Cell
74:269-280[CrossRef][Medline].
|
| 37.
|
Rippey, S. R.
1994.
Infectious diseases associated with molluscan shellfish consumption.
Clin. Microbiol. Rev.
7:419-425[Abstract/Free Full Text].
|
| 38.
|
Roberts, I. S.
1996.
The biochemistry and genetics of capsular polysaccharide production in bacteria.
Annu. Rev. Microbiol.
50:285-315[CrossRef][Medline].
|
| 39.
|
Sambrook, J.,
I. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning: a laboratory manual.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 40.
|
Shinoda, S.,
M. Kobayashi,
H. Yamada,
S. Yoshida,
M. Ogawa, and M. Mizuguchi.
1987.
Inhibitory effect of capsular antigen of Vibrio vulnificus on bactericidal activity of human serum.
Microbiol. Immunol.
31:393-401[Medline].
|
| 41.
|
Simpson, L. M.,
V. K. White,
S. F. Zane, and J. D. Oliver.
1987.
Correlation between virulence and colony morphology in Vibrio vulnificus.
Infect. Immun.
55:269-272[Abstract/Free Full Text].
|
| 42.
|
Starks, A. M.,
T. R. Schoeb,
M. L. Tamplin,
S. Parveen,
T. J. Doyle,
P. E. Bomeisl,
G. M. Escudero, and P. A. Gulig.
2000.
Pathogenesis of infection by clinical and environmental strains of Vibrio vulnificus in iron-dextran-treated mice.
Infect. Immun.
68:5785-5793[Abstract/Free Full Text].
|
| 43.
|
Stevenson, G.,
K. Andrianopoulos,
M. Hobbs, and P. R. Reeves.
1996.
Organization of the Escherichia coli K-12 gene cluster responsible for production of the extracellular polysaccharide colanic acid.
J. Bacteriol.
178:4885-4893[Abstract/Free Full Text].
|
| 44.
|
Stout, V.
1996.
Identification of the promoter region for the colanic acid polysaccharide biosynthetic genes in Escherichia coli K-12.
J. Bacteriol.
178:4273-4280[Abstract/Free Full Text].
|
| 45.
|
Strom, M. S., and R. N. Paranjpye.
2000.
Epidemiology and pathogenesis of Vibrio vulnificus.
Microb. Infect.
2:177-188[CrossRef][Medline].
|
| 46.
|
Tamplin, M. L.,
S. Specter,
G. E. Rodrick, and H. Friedman.
1985.
Vibrio vulnificus resists phagocytosis in the absence of serum opsonins.
Infect. Immun.
49:715-718[Abstract/Free Full Text].
|
| 47.
|
Whitfield, C., and I. S. Roberts.
1999.
Structure, assembly and regulation of expression of capsules in Escherichia coli.
Mol. Microbiol.
31:1307-1319[CrossRef][Medline].
|
| 48.
|
Wright, A. C.,
L. M. Simpson, and J. D. Oliver.
1981.
The role of iron in the pathogenesis of Vibrio vulnificus.
Infect. Immun.
34:503-507[Abstract/Free Full Text].
|
| 49.
|
Wright, A. C.,
L. M. Simpson,
J. D. Oliver, and J. G. Morris, Jr.
1990.
Phenotypic evaluation of acapsular transposon mutants of Vibrio vulnificus.
Infect. Immun.
58:1769-1773[Abstract/Free Full Text].
|
| 50.
|
Wright, A. C.,
G. A. Miceli,
W. L. Landry,
J. B. Christy,
W. D. Watkins, and J. G. Morris.
1993.
Rapid identification of Vibrio vulnificus on nonselective media with an alkaline phosphatase-labeled oligonucleotide probe.
Appl. Environ. Microbiol.
59:541-546[Abstract/Free Full Text].
|
| 51.
|
Wright, A. C.,
R. T. Hill,
J. A. Johnson,
R. R. Colwell, and J. G. Morris, Jr.
1996.
Distribution of V. vulnificus in the Chesapeake Bay.
Appl. Envron. Microbiol.
62:717-724[Abstract].
|
| 52.
|
Wright, A. C.,
J. L. Powell,
M. K. Tanner,
L. A. Ensor,
A. B. Karpas,
J. G. Morris, Jr., and M. B. Sztein.
1999.
Differential expression of Vibrio vulnificus capsular polysaccharide.
Infect. Immun.
67:2250-2257[Abstract/Free Full Text].
|
| 53.
|
Wunder, D. E.,
W. Aaronson,
S. F. Hayes,
J. M. Bliss, and R. P. Silver.
1994.
Nucleotide sequence and mutational analysis of the gene encoding KpsD, a periplasmic protein involved in transport of polysialic acid in Escherichia coli K1.
J. Bacteriol.
176:4025-4033[Abstract/Free Full Text].
|
| 54.
|
Yoshida, S. I.,
M. Ogawa, and Y. Mizuguchi.
1985.
Relation of capsular materials and colony opacity to Vibrio vulnificus.
Infect. Immun.
47:446-451[Abstract/Free Full Text].
|
| 55.
|
Zuppardo, A. B., and R. J. Siebeling.
1998.
An epimerase gene essential for capsule synthesis in Vibrio vulnificus.
Infect. Immun.
66:2601-2606[Abstract/Free Full Text].
|
Infection and Immunity, November 2001, p. 6893-6901, Vol. 69, No. 11
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.11.6893-6901.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Nakhamchik, A., Wilde, C., Rowe-Magnus, D. A.
(2008). Cyclic-di-GMP Regulates Extracellular Polysaccharide Production, Biofilm Formation, and Rugose Colony Development by Vibrio vulnificus. Appl. Environ. Microbiol.
74: 4199-4209
[Abstract]
[Full Text]
-
Grau, B. L., Henk, M. C., Garrison, K. L., Olivier, B. J., Schulz, R. M., O'Reilly, K. L., Pettis, G. S.
(2008). Further Characterization of Vibrio vulnificus Rugose Variants and Identification of a Capsular and Rugose Exopolysaccharide Gene Cluster. Infect. Immun.
76: 1485-1497
[Abstract]
[Full Text]
-
Valiente, E., Jimenez, N., Merino, S., Tomas, J. M., Amaro, C.
(2008). Vibrio vulnificus Biotype 2 Serovar E gne but Not galE Is Essential for Lipopolysaccharide Biosynthesis and Virulence. Infect. Immun.
76: 1628-1638
[Abstract]
[Full Text]
-
Nakhamchik, A., Wilde, C., Rowe-Magnus, D. A.
(2007). Identification of a Wzy Polymerase Required for Group IV Capsular Polysaccharide and Lipopolysaccharide Biosynthesis in Vibrio vulnificus. Infect. Immun.
75: 5550-5558
[Abstract]
[Full Text]
-
Tsuchiya, T., Mitsuo, E., Hayashi, N., Hikita, Y., Nakao, H., Yamamoto, S., Miyamoto, K., Tsujibo, H.
(2007). Vibrio vulnificus Damages Macrophages during the Early Phase of Infection. Infect. Immun.
75: 4592-4596
[Abstract]
[Full Text]
-
Bisharat, N., Amaro, C., Fouz, B., Llorens, A., Cohen, D. I.
(2007). Serological and molecular characteristics of Vibrio vulnificus biotype 3: evidence for high clonality. Microbiology
153: 847-856
[Abstract]
[Full Text]
-
Hilton, T., Rosche, T., Froelich, B., Smith, B., Oliver, J.
(2006). Capsular Polysaccharide Phase Variation in Vibrio vulnificus. Appl. Environ. Microbiol.
72: 6986-6993
[Abstract]
[Full Text]
-
Chatzidaki-Livanis, M., Hubbard, M. A., Gordon, K., Harwood, V. J., Wright, A. C.
(2006). Genetic Distinctions among Clinical and Environmental Strains of Vibrio vulnificus. Appl. Environ. Microbiol.
72: 6136-6141
[Abstract]
[Full Text]
-
Davey, M. E., Duncan, M. J.
(2006). Enhanced Biofilm Formation and Loss of Capsule Synthesis: Deletion of a Putative Glycosyltransferase in Porphyromonas gingivalis.. J. Bacteriol.
188: 5510-5523
[Abstract]
[Full Text]
-
Rosche, T. M., Smith, B., Oliver, J. D.
(2006). Evidence for an Intermediate Colony Morphology of Vibrio vulnificus.. Appl. Environ. Microbiol.
72: 4356-4359
[Abstract]
[Full Text]
-
Campisano, A., Schroeder, C., Schemionek, M., Overhage, J., Rehm, B. H. A.
(2006). PslD Is a Secreted Protein Required for Biofilm Formation by Pseudomonas aeruginosa. Appl. Environ. Microbiol.
72: 3066-3068
[Abstract]
[Full Text]
-
Smith, B., Oliver, J. D.
(2006). In Situ Gene Expression by Vibrio vulnificus.. Appl. Environ. Microbiol.
72: 2244-2246
[Abstract]
[Full Text]
-
Chatzidaki-Livanis, M., Jones, M. K., Wright, A. C.
(2006). Genetic Variation in the Vibrio vulnificus Group 1 Capsular Polysaccharide Operon.. J. Bacteriol.
188: 1987-1998
[Abstract]
[Full Text]
-
Smith, B., Oliver, J. D.
(2006). In Situ and In Vitro Gene Expression by Vibrio vulnificus during Entry into, Persistence within, and Resuscitation from the Viable but Nonculturable State. Appl. Environ. Microbiol.
72: 1445-1451
[Abstract]
[Full Text]
-
Park, N. Y., Lee, J. H., Kim, M. W., Jeong, H. G., Lee, B. C., Kim, T. S., Choi, S. H.
(2006). Identification of the Vibrio vulnificus wbpP Gene and Evaluation of Its Role in Virulence. Infect. Immun.
74: 721-728
[Abstract]
[Full Text]
-
Thompson, F. L., Iida, T., Swings, J.
(2004). Biodiversity of Vibrios. Microbiol. Mol. Biol. Rev.
68: 403-431
[Abstract]
[Full Text]
-
Joseph, L. A., Wright, A. C.
(2004). Expression of Vibrio vulnificus Capsular Polysaccharide Inhibits Biofilm Formation. J. Bacteriol.
186: 889-893
[Abstract]
[Full Text]
-
Campbell, M. S., Wright, A. C.
(2003). Real-Time PCR Analysis of Vibrio vulnificus from Oysters. Appl. Environ. Microbiol.
69: 7137-7144
[Abstract]
[Full Text]
-
Chen, C.-Y., Wu, K.-M., Chang, Y.-C., Chang, C.-H., Tsai, H.-C., Liao, T.-L., Liu, Y.-M., Chen, H.-J., Shen, A. B.-T., Li, J.-C., Su, T.-L., Shao, C.-P., Lee, C.-T., Hor, L.-I, Tsai, S.-F.
(2003). Comparative Genome Analysis of Vibrio vulnificus, a Marine Pathogen. Genome Res
13: 2577-2587
[Abstract]
[Full Text]
-
Guvener, Z. T., McCarter, L. L.
(2003). Multiple Regulators Control Capsular Polysaccharide Production in Vibrio parahaemolyticus. J. Bacteriol.
185: 5431-5441
[Abstract]
[Full Text]
-
Smith, A. B., Siebeling, R. J.
(2003). Identification of Genetic Loci Required for Capsular Expression in Vibrio vulnificus. Infect. Immun.
71: 1091-1097
[Abstract]
[Full Text]